Medication info
Candemore 16 mg Tablet (Candersartan Cilexetil)

Candemore 16 mg Tablet (Candersartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Pink, round, biconvex tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200903974 · Notified 2009.06.08 · Insurance code 643305140

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with reduced effective blood volume. 4) Patients with renal impairment: The initial dose in patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose in patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • left ventricular systolic dysfunction
  • reduced left ventricular ejection fraction
View approved original text

This medication is used to control essential hypertension. Additionally, it is effectively used for heart failure patients, particularly in cases where left ventricular systolic function is impaired, and further treatment with ACE inhibitors is needed or when there is poor tolerance to ACE inhibitors. Therefore, it helps in the management of hypertension and the treatment of specific heart failure.

How to take

Adult dose

Take this medicine at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg with careful monitoring in patients at increased risk of hypotension, such as those with reduced effective blood volume. 4) Patients with renal impairment: The initial dose in patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose in patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure Children: The safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters. Therefore, if pregnancy is confirmed, it should be discontinued immediately. It should not be used in patients with allergies to this medication or its components, in pregnant or nursing women, patients with severe liver impairment, and patients with hereditary angioedema. Careful use is required in elderly patients, patients with hyperkalemia, patients with liver impairment, patients with heart valve disease, and patients with poor kidney function. Regular checks of blood pressure, kidney function, and serum potassium levels should be conducted. Adverse effects such as dizziness, lower back pain, and respiratory infections may occur during the use of this medication. Rarely, serious blood abnormalities, liver dysfunction, skin rash, and worsening kidney function may develop, and if such symptoms occur, consultation with a medical professional is necessary. In particular, for heart failure patients, symptoms such as hypotension, hyperkalemia, and kidney damage may arise, thus requiring dose adjustments and regular check-ups. This medication can enhance the antihypertensive effects when taken with other antihypertensive drugs, and special caution is warranted as co-administration with certain diuretics or potassium supplements can lead to dangerously high serum potassium levels. Women who are pregnant or planning to become pregnant should avoid using this medication, and nursing mothers should also avoid taking this medication or discontinue breastfeeding. The safety and efficacy in children or adolescents under 18 years have not been established, so it is advisable not to use it in this population. Elderly patients should be especially cautious as excessive lowering of blood pressure may increase the risk of stroke. In cases of overdose, symptoms such as hypotension, dizziness, and rapid heart rate may occur, and immediate medical treatment should be sought. This medication should be kept out of reach of children and should not be transferred to another container for safety reasons.

Side effects

  • Dizziness
  • low back pain
  • respiratory infections
  • upper respiratory tract infections
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 67 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • asthenia
  • fever
  • sensory abnormalities
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • headache
  • bowel vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • memory loss
  • anorexia
  • increased appetite
  • tinnitus
  • taste distortion
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. Also, it is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication for a longer time.

Appearance and packaging

Appearance

Pink, round, biconvex tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.